David Godin, MD
Otolaryngology · New York, NYNPI 1053350686
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,777 of the $9,457 with a category attached, or 71.7%. 27 manufacturers reported payments, led by Sanofi at 41.9% of the total. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $42.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Medtronic$812
- Kaleo, Inc.$561
- Neurent Medical Limited$552
- Stryker$523
- GSK$513
- plus $3K from 21 others
What the payments were for
- Consulting fees$2,68028%
- Food & beverage$6,77772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 53 | $3,962 |
| Medtronic | 12 | $812 |
| Kaleo, Inc. | 26 | $561 |
| Neurent Medical Limited | 5 | $552 |
| Stryker | 9 | $523 |
| GSK | 22 | $513 |
| Optinose US, Inc. | 25 | $415 |
| Intersect ENT, Inc. | 5 | $363 |
| Aerin Medical Inc. | 5 | $345 |
| Regeneron Healthcare Solutions, Inc. | 8 | $284 |
| Novartis | 6 | $173 |
| Alk-abello, Inc | 8 | $137 |
| Teva Pharmaceuticals USA, Inc. | 5 | $110 |
| Boehringer Ingelheim | 4 | $97 |
| Amgen(2 entities) | 3 | $72 |
| Hikma Pharmaceuticals USA | 2 | $68 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| Integra Lifesciences Corporation | 2 | $59 |
| Smith+Nephew | 3 | $56 |
| Spirair, Inc. | 1 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| AstraZeneca | 2 | $47 |
| Phadia US Inc. | 2 | $34 |
| Merck | 1 | $21 |
| Acclarent, Inc | 1 | $21 |
| Octapharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,457 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 15 | $1,909 |
| Famotidine | 62 | $1,000 |
| Ipratropium Bromide | 36 | $999 |
| Mometasone Furoate | 13 | $187 |
| Methylprednisolone | 20 | $123 |
| Prednisone | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New York
- Roheen RaithathaNew York$830K
- Dennis KrausNew York$159K
- Anthony DelsignoreNew York$89K
- Satish GovindarajNew York$39K
- Lawrence LustigNew York$33K
- Justin GolubNew York$30K
- Brett MilesNew York$30K
- David HiltzikNew York$25K
- Milan AminNew York$23K
- Ashutosh KackerNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.